8-chloro-2-[1-[2-(3,3-difluoroazetidin-1-yl)ethyl]pyrazol-4-yl]-7-[(2-methyl-3H-benzimidazol-5-yl)oxy]quinoxaline

C24H20ClF2N7O — CID 164871024

IUPAC8-chloro-2-[1-[2-(3,3-difluoroazetidin-1-yl)ethyl]pyrazol-4-yl]-7-[(2-methyl-3H-benzimidazol-5-yl)oxy]quinoxaline
SMILESCc1nc2ccc(Oc3ccc4ncc(-c5cnn(CCN6CC(F)(F)C6)c5)nc4c3Cl)cc2[nH]1
InChIInChI=1S/C24H20ClF2N7O/c1-14-30-17-3-2-16(8-19(17)31-14)35-21-5-4-18-23(22(21)25)32-20(10-28-18)15-9-29-34(11-15)7-6-33-12-24(26,27)13-33/h2-5,8-11H,6-7,12-13H2,1H3,(H,30,31)
InChIKeyQBUBTWFOLQBIOA-UHFFFAOYSA-N
MW495.92 g/mol
LogP5.07
Rot. Bonds6

About 8-chloro-2-[1-[2-(3,3-difluoroazetidin-1-yl)ethyl]pyrazol-4-yl]-7-[(2-methyl-3H-benzimidazol-5-yl)oxy]quinoxaline

8-chloro-2-[1-[2-(3,3-difluoroazetidin-1-yl)ethyl]pyrazol-4-yl]-7-[(2-methyl-3H-benzimidazol-5-yl)oxy]quinoxaline (PubChem CID 164871024) has the molecular formula C24H20ClF2N7O and a molecular weight of 495.92 g/mol. Its IUPAC name is 8-chloro-2-[1-[2-(3,3-difluoroazetidin-1-yl)ethyl]pyrazol-4-yl]-7-[(2-methyl-3H-benzimidazol-5-yl)oxy]quinoxaline.

Molecular Properties

Compound Name8-chloro-2-[1-[2-(3,3-difluoroazetidin-1-yl)ethyl]pyrazol-4-yl]-7-[(2-methyl-3H-benzimidazol-5-yl)oxy]quinoxaline
PubChem CID164871024
Molecular FormulaC24H20ClF2N7O
Molecular Weight495.92 g/mol
Exact Mass495.14
IUPAC Name8-chloro-2-[1-[2-(3,3-difluoroazetidin-1-yl)ethyl]pyrazol-4-yl]-7-[(2-methyl-3H-benzimidazol-5-yl)oxy]quinoxaline
SMILESCc1nc2ccc(Oc3ccc4ncc(-c5cnn(CCN6CC(F)(F)C6)c5)nc4c3Cl)cc2[nH]1
InChIInChI=1S/C24H20ClF2N7O/c1-14-30-17-3-2-16(8-19(17)31-14)35-21-5-4-18-23(22(21)25)32-20(10-28-18)15-9-29-34(11-15)7-6-33-12-24(26,27)13-33/h2-5,8-11H,6-7,12-13H2,1H3,(H,30,31)
InChIKeyQBUBTWFOLQBIOA-UHFFFAOYSA-N
XLogP5.07
TPSA84.75 Ų
H-Bond Donors1
H-Bond Acceptors7
Rotatable Bonds6
Heavy Atoms35
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500495.92
LogP ≤ 55.07
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 107

Analyze 8-chloro-2-[1-[2-(3,3-difluoroazetidin-1-yl)ethyl]pyrazol-4-yl]-7-[(2-methyl-3H-benzimidazol-5-yl)oxy]quinoxaline with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 8-chloro-2-[1-[2-(3,3-difluoroazetidin-1-yl)ethyl]pyrazol-4-yl]-7-[(2-methyl-3H-benzimidazol-5-yl)oxy]quinoxaline?
The IUPAC name of 8-chloro-2-[1-[2-(3,3-difluoroazetidin-1-yl)ethyl]pyrazol-4-yl]-7-[(2-methyl-3H-benzimidazol-5-yl)oxy]quinoxaline (CID 164871024) is 8-chloro-2-[1-[2-(3,3-difluoroazetidin-1-yl)ethyl]pyrazol-4-yl]-7-[(2-methyl-3H-benzimidazol-5-yl)oxy]quinoxaline.
What is the SMILES notation for 8-chloro-2-[1-[2-(3,3-difluoroazetidin-1-yl)ethyl]pyrazol-4-yl]-7-[(2-methyl-3H-benzimidazol-5-yl)oxy]quinoxaline?
The canonical SMILES for 8-chloro-2-[1-[2-(3,3-difluoroazetidin-1-yl)ethyl]pyrazol-4-yl]-7-[(2-methyl-3H-benzimidazol-5-yl)oxy]quinoxaline is Cc1nc2ccc(Oc3ccc4ncc(-c5cnn(CCN6CC(F)(F)C6)c5)nc4c3Cl)cc2[nH]1.
What is the InChIKey of 8-chloro-2-[1-[2-(3,3-difluoroazetidin-1-yl)ethyl]pyrazol-4-yl]-7-[(2-methyl-3H-benzimidazol-5-yl)oxy]quinoxaline?
The InChIKey is QBUBTWFOLQBIOA-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H20ClF2N7O/c1-14-30-17-3-2-16(8-19(17)31-14)35-21-5-4-18-23(22(21)25)32-20(10-28-18)15-9-29-34(11-15)7-6-33-12-24(26,27)13-33/h2-5,8-11H,6-7,12-13H2,1H3,(H,30,31).
What are the key properties of 8-chloro-2-[1-[2-(3,3-difluoroazetidin-1-yl)ethyl]pyrazol-4-yl]-7-[(2-methyl-3H-benzimidazol-5-yl)oxy]quinoxaline?
8-chloro-2-[1-[2-(3,3-difluoroazetidin-1-yl)ethyl]pyrazol-4-yl]-7-[(2-methyl-3H-benzimidazol-5-yl)oxy]quinoxaline has a molecular weight of 495.92 g/mol, XLogP of 5.07, 6 rotatable bonds, 1 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 8-chloro-2-[1-[2-(3,3-difluoroazetidin-1-yl)ethyl]pyrazol-4-yl]-7-[(2-methyl-3H-benzimidazol-5-yl)oxy]quinoxaline is sourced from PubChem (CID 164871024), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).